Equasens SA
PAR:EQS
Equasens SA
PAR:EQS
Price:
55.7 EUR
0.36%
Market Closed
Updated:
May 11, 2024
Section:
Relative Value
The Relative Value of one
EQS
stock under the Base Case scenario is
78.86
EUR.
Compared to the current market price of 55.7 EUR,
Equasens SA
is
Undervalued by 29%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
EQS
Relative Value
Base Case
78.86
EUR
Undervaluation 29%
Valuation Multiples
Multiples Across Competitors
EQS Competitors Multiples
Equasens SA Competitors
Equasens SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FR |
|
Equasens SA
PAR:EQS
|
837.2m EUR | 3.8 | 17.8 | 12 | 15 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
32.9B USD | 13.9 | 62.5 | 62.4 | 67.2 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
12B AUD | 82.3 | 172.5 | 118.7 | 118.7 | |
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY | 4.7 | 23.8 | 12.3 | 13.9 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
5B USD | 7.5 | -316.4 | -137.9 | -126 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.4B USD | 9.3 | 31.6 | 21 | 22.4 | |
| SE |
|
Sectra AB
STO:SECT B
|
45.4B SEK | 27.7 | 107 | -70.5 | -70.5 | |
| US |
|
Evolent Health Inc
NYSE:EVH
|
2.8B USD | 1.4 | -19.6 | 23.4 | 249.3 | |
| US |
|
Vocera Communications Inc
NYSE:VCRA
|
2.8B USD | 11.7 | -324 | 264.4 | 4 233.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
